Torrent Pharma To Pay $323M For Elder's Formulations Biz
Indian drugmaker Torrent Pharmaceuticals Ltd. will purchase rival Elder Pharmaceuticals Ltd.'s branded domestic formulations business for more than 20 billion Indian rupees (about $323 million), the companies said Friday, in a...To view the full article, register now.
Already a subscriber? Click here to view full article